1. Home
  2. CRON vs STAA Comparison

CRON vs STAA Comparison

Compare CRON & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

HOLD

Current Price

$2.59

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$25.46

Market Cap

867.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRON
STAA
Founded
N/A
1982
Country
Canada
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
867.9M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
CRON
STAA
Price
$2.59
$25.46
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$22.81
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,587,000.00
$239,442,000.00
Revenue This Year
$26.34
$30.82
Revenue Next Year
$15.53
$8.41
P/E Ratio
N/A
N/A
Revenue Growth
24.63
N/A
52 Week Low
$1.81
$15.59
52 Week High
$3.43
$30.81

Technical Indicators

Market Signals
Indicator
CRON
STAA
Relative Strength Index (RSI) 47.55 61.77
Support Level $2.45 $23.75
Resistance Level $2.73 $27.52
Average True Range (ATR) 0.14 1.17
MACD -0.00 -0.00
Stochastic Oscillator 9.46 56.50

Price Performance

Historical Comparison
CRON
STAA

About CRON Cronos Group Inc.

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Share on Social Networks: